Skip to main content
OpenTrials

Clinical trial condition

Early Onset Severe Hemolytic Disease of the Fetus and Newborn (EOS-HDFN)

Explore clinical trials studying Early Onset Severe Hemolytic Disease of the Fetus and Newborn (EOS-HDFN). Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Early Onset Severe Hemolytic Disease of the Fetus and Newborn (EOS-HDFN) trial results

Completed

A Study to Characterize the Clinical Course of Pregnant Women and Children at High Risk for Early Onset Severe Hemolytic Disease of the Fetus and Newborn

NCT03755128

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Early Onset Severe Hemolytic Disease of the Fetus and Newborn (EOS-HDFN), Erythroblastosis, Fetal, +8 more
Locations
  • Columbia University Medical Center New York, United States
  • University of Cincinnati Cincinnati, Ohio, United States
  • Oregon Health and Science University Portland, Oregon, United States
  • UPMC Pittsburgh, Pennsylvania, United States
View all 18 locations
View Trial Details

Related conditions